This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Tenet's Tight Spot

Tenet Healthcare's (THC - Get Report) turnaround took an unexpected detour Monday.

Investors have been rooting for the hospital chain to shake its legal headaches. But they got bad news Monday, when the government threatened to bar a Tenet hospital from federal insurance payments.

The Office of Inspector General on Monday laid out plans to bar Tenet's Alvarado Hospital Medical Center in San Diego from treating patients covered by Medicare and other federal insurance programs. The rare threat, if carried out, would be a virtual death sentence for Alvarado.

The Justice Department has accused Alvarado of paying illegal kickbacks to physicians in exchange for patient referrals. The agency continues to investigate other Tenet facilities suspected of similar misconduct. Tenet has denied any wrongdoing, and two federal criminal kickback trials involving Alvarado and its former execs have ended in mistrials.

Many investors had assumed that the latest courtroom battle -- which dragged on for nearly a year before ending last month in a mistrial -- would finally wear the government down and pave the way for a global settlement as early as the first half of this year.

But now hopes for any near-term deal have started to fade. CRT Capital analyst Sheryl Skolnick promptly downgraded Tenet to sell from fair value as a result.

"The move by the OIG is a clear signal to us that the federal government ... is unwilling to cut THC even a little bit of slack," Skolnick wrote on Tuesday. "This development could mean that the Justice Department and the OIG are intent to take THC to task every and any way they can. ... This is clearly a setback for the global settlement, the turnaround and the stock, in our view."

Skolnick now estimates the breakup value of the company between $4.42 and $9.97 a share. She has set her 12-month target price on the stock at $6.43, just below the midpoint of that range.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
THC $46.30 0.00%
AAPL $128.46 0.00%
FB $78.97 0.00%
GOOG $558.40 0.00%
TSLA $203.34 0.00%


DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs